Are you looking for more information on Ketek? Visit http://www.ketek-legal-help.com/ for access to a wide variety of resources, including a Ketek Attorney, a Ketek Lawfirm, and information on a Ketek Lawsuit.
Drug Marketed in Asia Even After Toxicity Occurs in Similar Drug Ketek
According to news reports a new drug known as cethromycin, part of the ketolide drug class, will begin being marketed in Asia even though a similar medicine known as Ketek, from the same drug class, raised serious red flags among physicians and drug regulators when the antibiotic was linked to severe liver toxicity among patients leading to several fatalities.
Ketek is part of the class of drugs known as ketolide belonging to the macrolide group. The ketolide antibiotics are a new group of drugs that are used to treat respiratory infections. Ketek is currently the only known ketolide available on the market and because of severe issues with toxicity the U.S. Food and Drug Administration (FDA) have issued increased regulations for the drug. However, manufacturer Advanced Life Sciences and marketer Wyeth have continued with production of a similar ketolide even after safety concerns with the group of drugs, especially Ketek, caused a long-delay in the approval process of any new ketolide.
Ketek (telithromycin), which was made available for market in April 2004, is manufactured by Sanofi-Aventis and is used to treat the following conditions, according to the FDA:
In early 2006, an issue of the Annals of Internal Medicine reported the link between Ketek and the development of life-threatening liver toxicity among patients. Soon after, the FDA issued a health advisory to physicians who were giving patients prescriptions of Ketek to watch for symptoms of liver disease, as the risk was being investigated by the FDA. Among the risks doctors as well as patients were to watch for included:
In addition to developing liver damage or liver toxicity, patients are also at risk for developing pseudomembrane colitis, which is an intestine infection, as well as hosting a lengthy list of side effects such as:
Unfortunately the list of side effects continues, and all were found during Phase III clinical trials of the drug in which 4,780 patients were tested for the drug's side effects and treatment effectiveness.
Overcoming the Ketek Risks
While the FDA continues to investigate the approximately 12 cases of acute liver failure, four fatalities and 20 cases of liver damage among patients, the drug remains on the market. Patients continue to be exposed to the potential Ketek risks of developing liver failure and liver toxicity.
Patients consuming Ketek are encouraged to contact their general physician to discuss the potential Ketek side effects. Additionally, if a patient has suffered from the Ketek dangers they are advised to consult a legal professional, particularly an experienced pharmaceutical attorney who can provide a legal consultation as to the potential need for creating a Ketek class action. Because liver damage can gravely effect an individual's life it is important that the appropriate justice is sought and, this may result in monetary compensation for a Ketek victim.
Peter Kent is the best-selling author of 50 books and hundreds of articles for magazines and newspapers. He manages Legalview.com, a website hosting a variety of information on legal issues, including Ketek
Rate This Article
Add Comments
Send To Friends
Print 
Download as PDF